|
Disease |
|
|
|
Detail |
| hsa-let-7a |
|
Causal |
MicroRNA signature predicts survival and relapse in lung cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-137 |
|
Causal |
MicroRNA signature predicts survival and relapse in lung cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-182* |
|
Causal |
MicroRNA signature predicts survival and relapse in lung cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-372 |
|
Causal |
MicroRNA signature predicts survival and relapse in lung cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Causal |
MicroRNA signature predicts survival and relapse in lung cancer. |
2008 |
|
|
|
|
|
|
| hsa-let-7g |
|
Causal |
Suppression of non-small cell lung tumor development by the let-7 microRNA family. |
2008 |
|
|
|
|
|
|
| hsa-miR-15b |
|
Unspecified |
MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-9 |
|
Unspecified |
MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-96 |
|
Unspecified |
MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Causal |
MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Causal |
MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-100 |
|
Unspecified |
MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-125b |
|
Unspecified |
MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-34a |
|
Causal |
p53-mediated activation of miRNA34 candidate tumor-suppressor genes. |
2007 |
|
|
|
|
|
|
| hsa-miR-34b |
|
Causal |
p53-mediated activation of miRNA34 candidate tumor-suppressor genes. |
2007 |
|
|
|
|
|
|
| hsa-miR-34c |
|
Causal |
p53-mediated activation of miRNA34 candidate tumor-suppressor genes. |
2007 |
|
|
|
|
|
|
| hsa-miR-15a |
|
Causal |
miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-16 |
|
Causal |
miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-185 |
|
Causal |
MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. |
2009 |
|
|
|
|
|
|
| hsa-miR-107 |
|
Causal |
MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. |
2009 |
|
|
|
|
|
|
| hsa-miR-126 |
|
Causal |
MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. |
2008 |
|
|
|
|
|
|
| hsa-miR-205 |
|
Unspecified |
Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR.
|
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR.
|
2008 |
|
|
|
|
|
|
| hsa-let-7a |
|
Causal |
A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. |
2008 |
|
|
|
|
|
|
| hsa-let-7b |
|
Causal |
A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. |
2008 |
|
|
|
|
|
|
| hsa-let-7d |
|
Causal |
A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. |
2008 |
|
|
|
|
|
|
| hsa-let-7g |
|
Causal |
A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. |
2009 |
|
|
|
|
|
|